Physician profile
Neil J Thomas
NPI 1720070238
$7,131.16
in general payments reported to CMS, 2019-2025
11 companies · $353 in 2025
The $353 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,363 · 2020: $147 · 2021: $268 · 2025: $353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $337 · Food and Beverage: $16.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $336.95 |
| Food and Beverage | $16.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,602.89 | 2019-2020 | |
| Medtronic Vascular, INC. | $2,402.04 | 2019 | |
| Transmedics, INC. | $336.95 | 2025 | Organ Care System |
| Abiomed | $177.83 | 2019-2020 | |
| Medistim USA, INC. | $141.96 | 2019-2021 | |
| Atricure, INC. | $126.38 | 2019-2020 | |
| Medtronic, INC. | $112.30 | 2021 | |
| Novo Nordisk INC | $76.04 | 2021 | |
| Livanova USA, INC. | $71.70 | 2019 | |
| Boston Scientific Corporation | $67.01 | 2019 | |
| Chiesi USA, INC. | $16.06 | 2025 | Cleviprex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.